Pure Global

LASSOSTAR™ NAV Catheter - Electrophysiology cardiac catheter, single-use - ARTG 461914

Access comprehensive regulatory information for LASSOSTAR™ NAV Catheter - Electrophysiology cardiac catheter, single-use in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class III is registered under ARTG number 461914 and sponsored by Johnson & Johnson Medical Pty Ltd, manufactured by Biosense Webster Inc in United States of America. The device registration started on September 03, 2024.

This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.

Free Database
Powered by Pure Global AI
TGA ARTG Official Data
Class III
ARTG 461914
Class III
LASSOSTAR™ NAV Catheter - Electrophysiology cardiac catheter, single-use
ARTG ID: 461914
Good Name: Johnson & Johnson Medical Pty Ltd - LASSOSTAR™ NAV Catheter - Electrophysiology cardiac catheter, single-use
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Intended Purpose

The catheter is intended only for electrophysiological mapping (stimulation and recording) of cardiac structures. The catheter is also intended to interface with a compatible CARTO™ 3 System for visualization.

Device Classification
Risk Class
Class III
Product Type
Single Device Product
ARTG Category
General
Registration Information
ARTG ID
461914
Start Date
September 03, 2024
Effective Date
September 03, 2024
Manufacturer
Country
United States of America
Address
31 Technology Drive Suite 200, Irvine, California, 92618